`
`Case 1:18-cv-01363-CFC Document62 Page1of 5 PagelD #: 8235Filed 01/17/19
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`GENENTECH,INC. and CITY OF HOPE,
`
`Plaintiffs,
`
`Vv.
`
`C.A. No. 18-1363-CFC
`
`SAMSUNGBIOEPIS CO., LTD.,
`
`Defendant.
`
`
`anptorosnyo
`
`ORDER
`STIPULATION
`REGARDING AMENDED COMPLAINT
`
`WHEREAS, on September 4, 2018, Plaintiffs Genentech,
`
`Inc. and City of Hope
`
`(collectively, “Plaintiffs”) filed the above-captioned action against Defendant Samsung Bioepis
`
`Co., Ltd. (“Samsung”);
`
`WHEREAS,on November 7, 2018, pursuant to this Court’s scheduling order (D.I. 26),
`
`Plaintiffs sent Samsungaletter (the “Claim Narrowing Letter”) identifying allowed claims 10
`
`and 11 of U.S. App. No. 14/073,659 (“the ’659 application”) as among the narrowedset of
`
`patents and claimsto belitigated in this case once issued by the United States Patent Office;
`
`WHEREAS,on December 25, 2018, the United States Patent Office issued U.S. Patent
`
`No. 10,160,811 (“the 811 patent”) from the ’659 application;
`
`WHEREAS,claims6 and 7 ofthe °811 patent correspond to claims 10 and 11 of the ’659
`
`application;
`
`WHEREAS,pursuant to 42 U.S.C. § 262(/)(7), Plaintiffs have supplementedtheirlist of
`
`patents pursuant to 42 U.S.C. § 262(/)(3)(A)to include the ’811 patent, to the extent that the list
`
`of patents that Genentech provided to Bioepis on April 23, 2018, constitutes a list under to 42
`
`RLFI 20629538v.|
`
`-l-
`
`
`
`Case 1:18-cv-01363-CFC Document62-
`Filed 01/17/19
`Page 2 of 5 PagelD #: 8236
`Case 1:18-cv-01363-CFC Document 62 Filed 01/17/19 Page 2 of 5 PageID #: 8236
`
`U.S.C. § 262()(3)(A);
`
`WHEREAS,U.S. Patent No. 8,425,908 (‘the °908 patent”), originally asserted against
`
`Bioepis, has since expired and Bioepis’s biosimilar product was not approved by the FDA for
`
`marketing in the United States prior to the expiration of the °908 patent;
`
`WHEREAS,Plaintiffs seek leave to amend the Complaintin this action to (1) add a count
`
`of infringementof the 811 patent and (2) remove a countof infringementof the 908 patent, and
`
`Samsung does not oppose such amendment;
`
`NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED,byand between
`
`the undersigned parties and subject to the Court’s approval, that pursuant to Fed. R. Civ. P. 15(a)
`
`and D. Del. L.R. 15.1, and in the interests ofjudicial efficiency, the proposed amended pleading
`
`attached hereto as Exhibit 1, which adds a countof infringement of the ’811 patent and removes
`
`a count of infringement of the °908 patent, shall be docketed by the Court as the amended
`
`pleading and shall be deemed served upon entry of this Order. A form of the amended pleading
`
`indicating in what respectit differs from the pleading which it amendsis attached as Exhibit 2.
`
`Pursuant to the Court’s scheduling order (D.I. 26) and the Plaintiffs’ Claim Narrowing Letter, the
`
`claims of the °811 patent to be litigated in this case are claims 6 and 7.
`
`RLF1 20629538y.1
`
`
`
`Filed 01/17/19
`Page 3 of 5 PagelD #: 8237
`Case 1:18-cv-01363-CFC Document 62
`Case 1:18-cv-01363-CFC Document 62 Filed 01/17/19 Page 3 of 5 PageID #: 8237
`
`Dated: January 11, 2019
`
`
`/s/ Frederick L. Cottrell, Ill
`Frederick L, Cottrell, II] (#2555)
`Jason J. Rawnsley (#5379)
`Alexandra M. Ewing (#6407)
`RICHARDS, LAYTON & FINGER,P.A.
`920 North KingStreet
`Wilmington, DE 19801
`(302) 651-7700
`cottrell@rlf.com
`rawnsley@rlf.com
`ewing@rlf.com
`
`/s/ Bindu Palapura
`David E. Moore (#3983)
`Bindu Palapura (#5370)
`POTTER ANDERSON & CORROON LLP
`Hercules Plaza,6" Floor
`1313 North Market Street
`P.O. Box 951
`Wilmington, DE 19801
`(302) 984-6000
`dmoore@potteranderson.com
`bpalapura@potteranderson.com
`
`OF COUNSEL:
`
`Dimitrios T. Drivas
`Scott T. Weingaertner
`Amit H. Thakore
`Holly Tao
`WHITE & CASE LLP
`1221 Avenue of the Americas
`New York, NY 10020
`Tel: (212) 819-8200
`
`Attorneysfor Defendant Samsung Bioepis
`Co., Ltd.
`
`William F. Lee
`Lisa J. Pirozzolo
`Emily R. Whelan
`Kevin S. Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING
`HALE AND Dorr LLP
`60 State Street
`Boston, MA 02109
`(627) 526-6000
`william.lee@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`emily.whelan@wilmerhale.com
`kevin.prussia@wilmerhale.com
`andrew.danford@wilmerhale.com
`
`Robert J. GuntherJr.
`WILMER CUTLER PICKERING
`HALE AND DorR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`robert.gunther@wilmerhale.com
`
`Robert Galvin
`WILMER CUTLER PICKERING
`HALE AND DorR LLP
`
`RLF 1 20629538v.1
`
`
`
`Case 1:18-cv-01363-CFC Document 62 Filed 01/17/19 Page 4 of 5 PageID #: 8238
`Case 1:18-cv-01363-CFC
`Document62_
`Filed 01/17/19
`Page 4 of 5 PagelD #: 8238
`
`950 Page Mill Road
`Palo Alto, CA 94304
`(650) 858-6000
`robert.galvin@wilmerhale.com
`
`Daralyn J. Durie
`Adam R. Brausa
`DURIE TANGRI LLP
`217 LeidesdorffSt.
`San Francisco, CA 94111
`(415) 362-6666
`ddurie@durietangri.com
`abrausa@durietangri.com
`
`Attorneysfor Plaintiffs Genentech, Inc. and
`City ofHope
`
`RLF 1 20629538v.1
`
`
`
`
`Case 1:18-cv-01363-CFC Document62_Filed 01/17/19 Page 5 of 5 PagelD #: 8239
`Case 1:18-cv-01363-CFC Document 62 Filed 01/17/19 Page 5 of 5 PageID #: 8239
`
`SO ORDEREDthis [PEaay of Masser
`
`~
`
`, 2019,
`
` United States Distri
`
`RLF1 20629538v.!
`
`